Skip to main content
Erschienen in: Diabetologia 4/2009

01.04.2009 | Short Communication

A simple two-step protocol for the purification of human pancreatic beta cells

verfasst von: M. Banerjee, T. Otonkoski

Erschienen in: Diabetologia | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Isolated pure human beta cells would be helpful for a number of research purposes. However, lack of beta cell-specific surface antigens has been a major problem. We aimed to develop a simple method for human beta cell isolation based on the initial elimination of ductal cells by their expression of carbohydrate antigen 19-9 (CA19-9), followed by positive selection of beta cells by their expression of polysialic acid–neural cell adhesion molecule (PSA-NCAM).

Methods

Cell type-specific expression of CA19-9, NCAM and PSA-NCAM was studied in sections of adult human pancreas and in cultured primary endocrine and exocrine cells. Dispersed human islet cells were purified in two steps, after 4 days of suspension culture, by binding to magnetic microbeads coupled to antibodies against CA19-9 and PSA-NCAM.

Results

NCAM expression was detected in ducts and islets in the human pancreas. In contrast, PSA-NCAM immunoreactivity was detected only in islets. PSA-NCAM staining in dispersed cells revealed that the marker is expressed in all endocrine cell types, but not in duct cells. Purification of dispersed islet cells using PSA-NCAM microbeads alone did not completely eliminate contaminating duct cells. However, elimination of the duct cells by CA19-9 microbeads followed by positive sorting of the PSA-NCAM-positive cells in five consecutive islet preparations resulted in 90 to 98% pure endocrine cells, of which 89 to 97% were beta cells.

Conclusions/interpretation

We describe a simple and reproducible method for purification of viable human pancreatic beta cells devoid of exocrine acini and ducts.
Literatur
1.
Zurück zum Zitat Street CN, Lakey JR, Shapiro AM et al (2004) Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 53:3107–3114PubMedCrossRef Street CN, Lakey JR, Shapiro AM et al (2004) Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes 53:3107–3114PubMedCrossRef
2.
Zurück zum Zitat Lukowiak B, Vandewalle B, Riachy R et al (2001) Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49:519–528PubMed Lukowiak B, Vandewalle B, Riachy R et al (2001) Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J Histochem Cytochem 49:519–528PubMed
3.
Zurück zum Zitat Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef Parnaud G, Bosco D, Berney T et al (2008) Proliferation of sorted human and rat beta cells. Diabetologia 51:91–100PubMedCrossRef
4.
Zurück zum Zitat Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806–816PubMedCrossRef Pipeleers DG, in't Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806–816PubMedCrossRef
5.
Zurück zum Zitat Cirulli V, Baetens D, Rutishauser U, Halban PA, Orci L, Rouiller DG (1994) Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 107:1429–1436PubMed Cirulli V, Baetens D, Rutishauser U, Halban PA, Orci L, Rouiller DG (1994) Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci 107:1429–1436PubMed
6.
Zurück zum Zitat Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J (1988) The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240:53–57PubMedCrossRef Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J (1988) The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240:53–57PubMedCrossRef
7.
Zurück zum Zitat Bernard-Kargar C, Kassis N, Berthault MF, Pralong W, Ktorza A (2001) Sialylated form of the neural cell adhesion molecule (NCAM): a new tool for the identification and sorting of beta-cell subpopulations with different functional activity. Diabetes 50(Suppl 1):S125–S130PubMedCrossRef Bernard-Kargar C, Kassis N, Berthault MF, Pralong W, Ktorza A (2001) Sialylated form of the neural cell adhesion molecule (NCAM): a new tool for the identification and sorting of beta-cell subpopulations with different functional activity. Diabetes 50(Suppl 1):S125–S130PubMedCrossRef
8.
Zurück zum Zitat Gmyr V, Belaich S, Muharram G et al (2004) Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9. Biochem Biophys Res Commun 320:27–33PubMedCrossRef Gmyr V, Belaich S, Muharram G et al (2004) Rapid purification of human ductal cells from human pancreatic fractions with surface antibody CA19-9. Biochem Biophys Res Commun 320:27–33PubMedCrossRef
9.
Zurück zum Zitat Yatoh S, Dodge R, Akashi T et al (2007) Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes 56:1802–1809PubMedCrossRef Yatoh S, Dodge R, Akashi T et al (2007) Differentiation of affinity-purified human pancreatic duct cells to beta-cells. Diabetes 56:1802–1809PubMedCrossRef
10.
Zurück zum Zitat Gao R, Ustinov J, Korsgren O, Otonkoski T (2005) In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 48:2296–2304PubMedCrossRef Gao R, Ustinov J, Korsgren O, Otonkoski T (2005) In vitro neogenesis of human islets reflects the plasticity of differentiated human pancreatic cells. Diabetologia 48:2296–2304PubMedCrossRef
11.
Zurück zum Zitat Ichii H, Miki A, Yamamoto T et al (2008) Characterization of pancreatic ductal cells in human islet preparations. Lab Invest 88:1167–1177PubMedCrossRef Ichii H, Miki A, Yamamoto T et al (2008) Characterization of pancreatic ductal cells in human islet preparations. Lab Invest 88:1167–1177PubMedCrossRef
Metadaten
Titel
A simple two-step protocol for the purification of human pancreatic beta cells
verfasst von
M. Banerjee
T. Otonkoski
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 4/2009
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1259-1

Weitere Artikel der Ausgabe 4/2009

Diabetologia 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.